Our previous work showed that biologically active albumin nanoparticles can effectively target solid tumors via GP60 and SPARC pathways and can effectively inhibit tumor growth and prolong the survival time of tumor-bearing mice (Meng et al., 2023). Here, SPARC is linked to neoplasm.